AP
NBSE

Americana Partners’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Americana Partners’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-13
Closed -$1K – 523
2019
Q4 		$1K Buy
+13
New +$1.52K ﹤0.01% 571

Other funds holding NBSE

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PPCM
Pillar Pacific Capital Management Pacifica, California $1.29B AUM 80.18% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Americana Partners's NBSE Position: Q1 2020 in Review

Americana Partners sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2020, closing a stake of 13 shares — an estimated $1K sold.

Americana Partners first reported a position in NBSE in Q4 2019 and held it in 1 quarter. The position peaked at $1K in Q4 2019. 25 funds tracked by Wall St. Rank hold NBSE as of Q1 2020.

  • Americana Partners reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Americana Partners sold 13 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $1K.
  • Americana Partners first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Americana Partners's NeuBase Therapeutics, Inc. Common Stock position peaked at $1K in Q4 2019.
  • 25 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Americana Partners's 13F filing for Q1 2020, filed 12 May 2020.